| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |